A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Part of paid clinical trials in Miami Beach, Florida.
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Study ID
- NCT05277168
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
- Advanced Solid Tumors
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- SHR-A1904 — DRUGSingle Arm :It is a dose-escalation and dose-expansion study of SHR-A1904 in subjects with advanced solid tumors
Study Details
The study (dose escalation/expansion) is being conducted to assess the safety and tolerability of SHR-A1904 in subjects with advanced solid tumors, and to determine maximum tolerated dose (MTD) and/or recommended phase II dose (RP2D), to assess preliminary efficacy of SHR-A1904, pharmacokinetic (PK) profile and immunogenicity of SHR-A1904 in subjects with advanced solid tumors.
Key Dates
- Start date
- May 30, 2022
- Status verified
- May 2026
- Primary completion
- May 31, 2026
- Completion
- May 31, 2026
Study Design
- Enrollment
- 83 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Single ArmSingle Arm : SHR-A1904
Primary Outcome Measure
Dose-limiting toxicity (DLT) [ Time Frame: The first cycle of administration, up to 21 days. ]
Central Contacts
- Bo Chao+41 79 47 68 792
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | - |
| Comprehensive Hematology Oncology | St. Petersburg | Florida | 33709 | - |
| LSU Health Sciences Center | New Orleans | Louisiana | 70112 | - |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | - |
| Rhode Island Hospital | Providence | Rhode Island | 02905 | - |
| Prisma Health | Greenville | South Carolina | 29605 | - |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | - |
Find similar trials in Miami Beach, FL
Related Studies
- TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerPHASE2 · Recruiting · American Society of Clinical Oncology · Birmingham, Alabama
- A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced CancersPHASE1/PHASE2 · Recruiting · Regeneron Pharmaceuticals · Los Angeles, California
- A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)PHASE1 · Recruiting · Merck Sharp & Dohme LLC · Tampa, Florida
- Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASPHASE1/PHASE2 · Recruiting · Revolution Medicines, Inc. · Orange, California